DK1139101T3 - Immunobestemmelse for C-reaktivt protein - Google Patents

Immunobestemmelse for C-reaktivt protein

Info

Publication number
DK1139101T3
DK1139101T3 DK01303068T DK01303068T DK1139101T3 DK 1139101 T3 DK1139101 T3 DK 1139101T3 DK 01303068 T DK01303068 T DK 01303068T DK 01303068 T DK01303068 T DK 01303068T DK 1139101 T3 DK1139101 T3 DK 1139101T3
Authority
DK
Denmark
Prior art keywords
immunoassay
antibody
antiidiotypic
reactive protein
monoclonal antibody
Prior art date
Application number
DK01303068T
Other languages
English (en)
Inventor
Edward R Scalice
John L Daiss
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Application granted granted Critical
Publication of DK1139101T3 publication Critical patent/DK1139101T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4737—C-reactive protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/965—Chemistry: molecular biology and microbiology involving idiotype or anti-idiotype antibody
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK01303068T 2000-03-31 2001-03-30 Immunobestemmelse for C-reaktivt protein DK1139101T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19395100P 2000-03-31 2000-03-31

Publications (1)

Publication Number Publication Date
DK1139101T3 true DK1139101T3 (da) 2006-04-10

Family

ID=22715702

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01303068T DK1139101T3 (da) 2000-03-31 2001-03-30 Immunobestemmelse for C-reaktivt protein

Country Status (8)

Country Link
US (1) US6838250B2 (da)
EP (1) EP1139101B1 (da)
JP (1) JP5031148B2 (da)
AT (1) ATE314653T1 (da)
DE (1) DE60116172T2 (da)
DK (1) DK1139101T3 (da)
ES (1) ES2254330T3 (da)
HK (1) HK1038069A1 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1565570A4 (en) * 2002-11-12 2005-12-28 Becton Dickinson Co DIAGNOSIS OF SEPTICEMIA OR SIRS USING BIOMARKER PROFILES
US20050136055A1 (en) 2003-12-22 2005-06-23 Pfizer Inc CD40 antibody formulation and methods
US20060154276A1 (en) 2004-05-13 2006-07-13 Prometheus Laboratories Inc. Methods of diagnosing inflammatory bowel disease
WO2006004039A1 (ja) * 2004-07-02 2006-01-12 Sanwa Kagaku Kenkyusho Co., Ltd. 免疫測定装置及び方法
KR20080006617A (ko) * 2005-04-15 2008-01-16 백톤 디킨슨 앤드 컴퍼니 패혈증의 진단
US20060246522A1 (en) * 2005-04-28 2006-11-02 Bhullar Balwant S C-reactive protein immunoassay and method
JP5097557B2 (ja) * 2005-12-22 2012-12-12 ローム株式会社 免疫測定装置及び方法
US8383350B1 (en) 2006-12-20 2013-02-26 Merck Sharp & Dohme Corp. Assay for detection of IL-10 antibodies
WO2009032128A1 (en) 2007-08-28 2009-03-12 Abbott Biotechnology Ltd. Compositions and methods comprising binding proteins for adalimumab
JP4970217B2 (ja) * 2007-11-07 2012-07-04 株式会社東芝 物質の測定方法
US8669113B2 (en) 2008-04-03 2014-03-11 Becton, Dickinson And Company Advanced detection of sepsis
JP5265257B2 (ja) * 2008-06-30 2013-08-14 富士フイルム株式会社 犬ｃｒｐ及び人ｃｒｐを認識する抗体
AU2009314259B2 (en) 2008-11-11 2015-06-11 Nestec S.A. Methods for prediction of inflammatory bowel disease (IBD) using serologic markers
JP5807300B2 (ja) * 2008-11-18 2015-11-10 株式会社シノテスト 試料中のｃ反応性蛋白質の測定方法及び測定試薬
NZ619527A (en) 2009-04-14 2015-06-26 Nestec Sa Inflammatory bowel disease prognostics
EP2445517B1 (en) 2009-06-25 2014-07-30 Nestec S.A. Methods for diagnosing irritable bowel syndrome
WO2011060098A1 (en) 2009-11-10 2011-05-19 Prometheus Laboratories Inc. Methods for predicting post-surgery risk associated with ileal pouch-anal anastomosis
PT2569013T (pt) * 2010-05-14 2017-02-08 Univ Leland Stanford Junior Anticorpos monoclonais humanizados e quiméricos para cd47
EP2630495B1 (en) 2010-10-18 2017-02-08 Nestec S.A. Methods for determining anti-drug antibody isotypes
CN103502815B (zh) 2011-02-17 2015-09-23 雀巢产品技术援助有限公司 检测针对抗-TNFα药物的自身抗体的测定法
MX2013012284A (es) 2011-04-29 2013-11-21 Bristol Myers Squibb Co Regimenes de elevacion de dosis del anticuerpo de proteina 10 inducible por interferon gamma (ip-10).
CA2839792A1 (en) 2011-05-10 2012-11-15 Nestec S.A. Methods of disease activity profiling for personalized therapy management
JP2015502740A (ja) 2011-10-21 2015-01-29 ネステク ソシエテ アノニム 炎症性腸疾患の診断を改善するための方法
PL2797951T3 (pl) 2011-12-28 2018-07-31 Immunoqure Ag Sposób izolacji ludzkich przeciwciał
WO2014054013A1 (en) 2012-10-05 2014-04-10 Nestec S.A. Methods for predicting and monitoring mucosal healing
SG11201509370UA (en) 2013-05-24 2015-12-30 Nestec Sa Pathway specific assays for predicting irritable bowel syndrome diagnosis
US10112995B2 (en) 2013-07-03 2018-10-30 Immunoqure Ag Human anti-IFN-α antibodies
CN105683755B (zh) 2013-11-05 2019-08-13 豪夫迈·罗氏有限公司 陷阱分子和检测分子的用途及其相关试剂盒和组合物
CA2932571A1 (en) 2013-12-03 2015-06-11 Nestec S.A. Methods for predicting post-operative recurrence of crohn's disease
WO2015166461A1 (en) 2014-05-01 2015-11-05 Nestec S.A. Methods of selecting treatment regimen using tnf alpha and anti-tnf alpha drug levels
EP3227685A1 (en) 2014-12-02 2017-10-11 Nestec S.A. Methods for establishing a vedolizumab dosing regimen to treat patients with irritable bowel disease
AU2016349703A1 (en) 2015-11-06 2018-11-01 Vetica Labs, Inc. Methods of detecting inflammatory markers and treating inflammatory conditions in companion animals
CN108279229B (zh) * 2017-01-05 2024-02-27 深圳市帝迈生物技术有限公司 一种全血crp检测装置
WO2019073391A1 (en) 2017-10-10 2019-04-18 Nestec S.A. METHODS OF MONITORING VEDOLIZUMAB TREATMENT
CN112051403A (zh) * 2020-08-27 2020-12-08 武汉生之源生物科技股份有限公司 C反应蛋白化学发光免疫检测试剂盒及其制备方法和应用
EP4357778A1 (en) 2022-10-20 2024-04-24 Heraeus Medical GmbH Treatment of microbial infections diagnosed using the biomarker d-lactate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219730A (en) 1982-09-28 1993-06-15 New York University Idiotype-anti-idiotype immunoassay
US4828981A (en) 1983-08-24 1989-05-09 Synbiotics Corporation Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents
US4699880A (en) 1984-09-25 1987-10-13 Immunomedics, Inc. Method of producing monoclonal anti-idiotype antibody
EP0210410B1 (en) * 1985-07-22 1992-05-20 Abbott Laboratories Fluorescence polarization immunoassay and reagents for measurement of c-reactive protein
WO1991000872A1 (en) 1989-06-27 1991-01-24 Rush-Presbyterian-St. Luke's Medical Centre Monoclonal antibodies to c-reactive protein
JP3174402B2 (ja) * 1992-06-08 2001-06-11 三洋化成工業株式会社 競合法による免疫測定法および測定用キット
JPH10282098A (ja) * 1997-04-11 1998-10-23 Matsushita Electric Ind Co Ltd 蛍光免疫測定法

Also Published As

Publication number Publication date
EP1139101A9 (en) 2002-03-20
US6838250B2 (en) 2005-01-04
EP1139101A2 (en) 2001-10-04
JP2002040024A (ja) 2002-02-06
HK1038069A1 (en) 2002-03-01
DE60116172T2 (de) 2006-08-03
EP1139101B1 (en) 2005-12-28
EP1139101A3 (en) 2002-05-15
ATE314653T1 (de) 2006-01-15
JP5031148B2 (ja) 2012-09-19
ES2254330T3 (es) 2006-06-16
US20020142356A1 (en) 2002-10-03
DE60116172D1 (de) 2006-02-02

Similar Documents

Publication Publication Date Title
DK1139101T3 (da) Immunobestemmelse for C-reaktivt protein
ATE487946T1 (de) Analytischer sandwichtest zur bestimmung von nt- probnp
RS50477B (sr) Anti-il-12 antitela, kompozicije, metode i njihove upotrebe
ATE554390T1 (de) Verfahren zur gewinnung von antikörpern
EA200500643A1 (ru) Способ неконкурентного иммуноанализа для определения малых аналитов
DK1232392T3 (da) Forbedret fremgangsmåde til påvisning af syreresistente bakterier af slægten Helicobacter i afføring
TW200516083A (en) Methods for making dual specificity antibodies
RS51197B (sr) Anti-dual integrinska antitela, sastavi, metode i njihove upotrebe
NZ547157A (en) Interferon Alpha Antibodies and their uses
ES2184660T1 (es) Anticuerpos humanizados que secuestran peptidos abeta.
DK1565489T3 (da) Internaliserende antistoffer specifikke for RAAG10-celleoverflademålet
ATE474226T1 (de) Taxol-immunoassay
WO2004025248A3 (en) Antibody pair screening methods
WO1998023955A3 (de) ANTIGENSPEZIFISCHER IgM-NACHWEIS
DE60235588D1 (de) Monoklonales Antikörper gegen das HCV Kernantigen
NO20051715L (no) HCV assay
DK1167389T3 (da) Antistoffer mod SEMP1-proteinet, fremgangsmåde til fremstilling heraf samt anvendelse deraf
DE60222816D1 (de) Identifizierung hochaffiner moleküle durch screening mit begrenzter verdünnung
CA2589054A1 (en) Detection of a therapeutic antibody in an experimental animal
MX9401112A (es) Preparacion de conjugados de fotoproteina y metodos para utilizar los mismos.
DE50210021D1 (de) Antikörper zum spezifischen Nachweis von pathogenen Prionen humanen Ursprungs und damit durchgeführte Nachweisverfahren
ATE282830T1 (de) Immuntest für human chromogranine a (cga), antikörper, reagenz und dazu geeigneter testsatz
DE60323105D1 (de) Verfahren zur beseitigung von störungen in immunochromatographischen assays
WO2002076406A3 (en) Antibodies against autoantigens of primary biliary cirrhosis and methods of making and using them
ES2126608T3 (es) Procedimiento para la determinacion de antigenos o anticuerpos en presencia de un inmunocomplejo.